Pharma & Healthcare
Global Zonisamide Market Research Report 2024
- Jan 18, 24
- ID: 3158
- Pages: 93
- Figures: 205
- Views: 22
Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
The global Zonisamide market was valued at US$ 489 million in 2023 and is anticipated to reach US$ 718.8 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Zonisamide include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Zonisamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zonisamide.
Report Scope
The Zonisamide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zonisamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zonisamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Segment by Type
25mg
50mg
100mg
Segment by Application
Adult
Pediatric
Geriatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Zonisamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Zonisamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Zonisamide market was valued at US$ 489 million in 2023 and is anticipated to reach US$ 718.8 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Zonisamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Zonisamide include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Zonisamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zonisamide.
Report Scope
The Zonisamide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zonisamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zonisamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Segment by Type
25mg
50mg
100mg
Segment by Application
Adult
Pediatric
Geriatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Zonisamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Zonisamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Zonisamide Market Overview
1.1 Product Overview and Scope of Zonisamide
1.2 Zonisamide Segment by Type
1.2.1 Global Zonisamide Market Value Comparison by Type (2024-2030)
1.2.2 25mg
1.2.3 50mg
1.2.4 100mg
1.3 Zonisamide Segment by Application
1.3.1 Global Zonisamide Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Pediatric
1.3.4 Geriatric
1.4 Global Zonisamide Market Size Estimates and Forecasts
1.4.1 Global Zonisamide Revenue 2019-2030
1.4.2 Global Zonisamide Sales 2019-2030
1.4.3 Global Zonisamide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Zonisamide Market Competition by Manufacturers
2.1 Global Zonisamide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Zonisamide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Zonisamide Average Price by Manufacturers (2019-2024)
2.4 Global Zonisamide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Zonisamide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Zonisamide, Product Type & Application
2.7 Zonisamide Market Competitive Situation and Trends
2.7.1 Zonisamide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Zonisamide Players Market Share by Revenue
2.7.3 Global Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Zonisamide Retrospective Market Scenario by Region
3.1 Global Zonisamide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Zonisamide Global Zonisamide Sales by Region: 2019-2030
3.2.1 Global Zonisamide Sales by Region: 2019-2024
3.2.2 Global Zonisamide Sales by Region: 2025-2030
3.3 Global Zonisamide Global Zonisamide Revenue by Region: 2019-2030
3.3.1 Global Zonisamide Revenue by Region: 2019-2024
3.3.2 Global Zonisamide Revenue by Region: 2025-2030
3.4 North America Zonisamide Market Facts & Figures by Country
3.4.1 North America Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Zonisamide Sales by Country (2019-2030)
3.4.3 North America Zonisamide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Zonisamide Market Facts & Figures by Country
3.5.1 Europe Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Zonisamide Sales by Country (2019-2030)
3.5.3 Europe Zonisamide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Zonisamide Market Facts & Figures by Country
3.6.1 Asia Pacific Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Zonisamide Sales by Country (2019-2030)
3.6.3 Asia Pacific Zonisamide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Zonisamide Market Facts & Figures by Country
3.7.1 Latin America Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Zonisamide Sales by Country (2019-2030)
3.7.3 Latin America Zonisamide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Zonisamide Market Facts & Figures by Country
3.8.1 Middle East and Africa Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Zonisamide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Zonisamide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Zonisamide Sales by Type (2019-2030)
4.1.1 Global Zonisamide Sales by Type (2019-2024)
4.1.2 Global Zonisamide Sales by Type (2025-2030)
4.1.3 Global Zonisamide Sales Market Share by Type (2019-2030)
4.2 Global Zonisamide Revenue by Type (2019-2030)
4.2.1 Global Zonisamide Revenue by Type (2019-2024)
4.2.2 Global Zonisamide Revenue by Type (2025-2030)
4.2.3 Global Zonisamide Revenue Market Share by Type (2019-2030)
4.3 Global Zonisamide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Zonisamide Sales by Application (2019-2030)
5.1.1 Global Zonisamide Sales by Application (2019-2024)
5.1.2 Global Zonisamide Sales by Application (2025-2030)
5.1.3 Global Zonisamide Sales Market Share by Application (2019-2030)
5.2 Global Zonisamide Revenue by Application (2019-2030)
5.2.1 Global Zonisamide Revenue by Application (2019-2024)
5.2.2 Global Zonisamide Revenue by Application (2025-2030)
5.2.3 Global Zonisamide Revenue Market Share by Application (2019-2030)
5.3 Global Zonisamide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Concordia
6.1.1 Concordia Corporation Information
6.1.2 Concordia Description and Business Overview
6.1.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Concordia Zonisamide Product Portfolio
6.1.5 Concordia Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Zonisamide Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Zydus Pharmaceuticals
6.3.1 Zydus Pharmaceuticals Corporation Information
6.3.2 Zydus Pharmaceuticals Description and Business Overview
6.3.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zydus Pharmaceuticals Zonisamide Product Portfolio
6.3.5 Zydus Pharmaceuticals Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharma Zonisamide Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Corporation Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wockhardt Zonisamide Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Zonisamide Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 APOTEX
6.6.1 APOTEX Corporation Information
6.6.2 APOTEX Description and Business Overview
6.6.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 APOTEX Zonisamide Product Portfolio
6.7.5 APOTEX Recent Developments/Updates
6.8 Teva
6.8.1 Teva Corporation Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Zonisamide Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Glenmark
6.9.1 Glenmark Corporation Information
6.9.2 Glenmark Description and Business Overview
6.9.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Glenmark Zonisamide Product Portfolio
6.9.5 Glenmark Recent Developments/Updates
6.10 Bluepharma
6.10.1 Bluepharma Corporation Information
6.10.2 Bluepharma Description and Business Overview
6.10.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bluepharma Zonisamide Product Portfolio
6.10.5 Bluepharma Recent Developments/Updates
6.11 Invagen Pharmaceuticals
6.11.1 Invagen Pharmaceuticals Corporation Information
6.11.2 Invagen Pharmaceuticals Zonisamide Description and Business Overview
6.11.3 Invagen Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Invagen Pharmaceuticals Zonisamide Product Portfolio
6.11.5 Invagen Pharmaceuticals Recent Developments/Updates
6.12 Intas Pharmaceuticals
6.12.1 Intas Pharmaceuticals Corporation Information
6.12.2 Intas Pharmaceuticals Zonisamide Description and Business Overview
6.12.3 Intas Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Intas Pharmaceuticals Zonisamide Product Portfolio
6.12.5 Intas Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Zonisamide Industry Chain Analysis
7.2 Zonisamide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Zonisamide Production Mode & Process
7.4 Zonisamide Sales and Marketing
7.4.1 Zonisamide Sales Channels
7.4.2 Zonisamide Distributors
7.5 Zonisamide Customers
8 Zonisamide Market Dynamics
8.1 Zonisamide Industry Trends
8.2 Zonisamide Market Drivers
8.3 Zonisamide Market Challenges
8.4 Zonisamide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Zonisamide
1.2 Zonisamide Segment by Type
1.2.1 Global Zonisamide Market Value Comparison by Type (2024-2030)
1.2.2 25mg
1.2.3 50mg
1.2.4 100mg
1.3 Zonisamide Segment by Application
1.3.1 Global Zonisamide Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Pediatric
1.3.4 Geriatric
1.4 Global Zonisamide Market Size Estimates and Forecasts
1.4.1 Global Zonisamide Revenue 2019-2030
1.4.2 Global Zonisamide Sales 2019-2030
1.4.3 Global Zonisamide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Zonisamide Market Competition by Manufacturers
2.1 Global Zonisamide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Zonisamide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Zonisamide Average Price by Manufacturers (2019-2024)
2.4 Global Zonisamide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Zonisamide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Zonisamide, Product Type & Application
2.7 Zonisamide Market Competitive Situation and Trends
2.7.1 Zonisamide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Zonisamide Players Market Share by Revenue
2.7.3 Global Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Zonisamide Retrospective Market Scenario by Region
3.1 Global Zonisamide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Zonisamide Global Zonisamide Sales by Region: 2019-2030
3.2.1 Global Zonisamide Sales by Region: 2019-2024
3.2.2 Global Zonisamide Sales by Region: 2025-2030
3.3 Global Zonisamide Global Zonisamide Revenue by Region: 2019-2030
3.3.1 Global Zonisamide Revenue by Region: 2019-2024
3.3.2 Global Zonisamide Revenue by Region: 2025-2030
3.4 North America Zonisamide Market Facts & Figures by Country
3.4.1 North America Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Zonisamide Sales by Country (2019-2030)
3.4.3 North America Zonisamide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Zonisamide Market Facts & Figures by Country
3.5.1 Europe Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Zonisamide Sales by Country (2019-2030)
3.5.3 Europe Zonisamide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Zonisamide Market Facts & Figures by Country
3.6.1 Asia Pacific Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Zonisamide Sales by Country (2019-2030)
3.6.3 Asia Pacific Zonisamide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Zonisamide Market Facts & Figures by Country
3.7.1 Latin America Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Zonisamide Sales by Country (2019-2030)
3.7.3 Latin America Zonisamide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Zonisamide Market Facts & Figures by Country
3.8.1 Middle East and Africa Zonisamide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Zonisamide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Zonisamide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Zonisamide Sales by Type (2019-2030)
4.1.1 Global Zonisamide Sales by Type (2019-2024)
4.1.2 Global Zonisamide Sales by Type (2025-2030)
4.1.3 Global Zonisamide Sales Market Share by Type (2019-2030)
4.2 Global Zonisamide Revenue by Type (2019-2030)
4.2.1 Global Zonisamide Revenue by Type (2019-2024)
4.2.2 Global Zonisamide Revenue by Type (2025-2030)
4.2.3 Global Zonisamide Revenue Market Share by Type (2019-2030)
4.3 Global Zonisamide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Zonisamide Sales by Application (2019-2030)
5.1.1 Global Zonisamide Sales by Application (2019-2024)
5.1.2 Global Zonisamide Sales by Application (2025-2030)
5.1.3 Global Zonisamide Sales Market Share by Application (2019-2030)
5.2 Global Zonisamide Revenue by Application (2019-2030)
5.2.1 Global Zonisamide Revenue by Application (2019-2024)
5.2.2 Global Zonisamide Revenue by Application (2025-2030)
5.2.3 Global Zonisamide Revenue Market Share by Application (2019-2030)
5.3 Global Zonisamide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Concordia
6.1.1 Concordia Corporation Information
6.1.2 Concordia Description and Business Overview
6.1.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Concordia Zonisamide Product Portfolio
6.1.5 Concordia Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Zonisamide Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Zydus Pharmaceuticals
6.3.1 Zydus Pharmaceuticals Corporation Information
6.3.2 Zydus Pharmaceuticals Description and Business Overview
6.3.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zydus Pharmaceuticals Zonisamide Product Portfolio
6.3.5 Zydus Pharmaceuticals Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharma Zonisamide Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Corporation Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wockhardt Zonisamide Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Zonisamide Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 APOTEX
6.6.1 APOTEX Corporation Information
6.6.2 APOTEX Description and Business Overview
6.6.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 APOTEX Zonisamide Product Portfolio
6.7.5 APOTEX Recent Developments/Updates
6.8 Teva
6.8.1 Teva Corporation Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Zonisamide Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Glenmark
6.9.1 Glenmark Corporation Information
6.9.2 Glenmark Description and Business Overview
6.9.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Glenmark Zonisamide Product Portfolio
6.9.5 Glenmark Recent Developments/Updates
6.10 Bluepharma
6.10.1 Bluepharma Corporation Information
6.10.2 Bluepharma Description and Business Overview
6.10.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bluepharma Zonisamide Product Portfolio
6.10.5 Bluepharma Recent Developments/Updates
6.11 Invagen Pharmaceuticals
6.11.1 Invagen Pharmaceuticals Corporation Information
6.11.2 Invagen Pharmaceuticals Zonisamide Description and Business Overview
6.11.3 Invagen Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Invagen Pharmaceuticals Zonisamide Product Portfolio
6.11.5 Invagen Pharmaceuticals Recent Developments/Updates
6.12 Intas Pharmaceuticals
6.12.1 Intas Pharmaceuticals Corporation Information
6.12.2 Intas Pharmaceuticals Zonisamide Description and Business Overview
6.12.3 Intas Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Intas Pharmaceuticals Zonisamide Product Portfolio
6.12.5 Intas Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Zonisamide Industry Chain Analysis
7.2 Zonisamide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Zonisamide Production Mode & Process
7.4 Zonisamide Sales and Marketing
7.4.1 Zonisamide Sales Channels
7.4.2 Zonisamide Distributors
7.5 Zonisamide Customers
8 Zonisamide Market Dynamics
8.1 Zonisamide Industry Trends
8.2 Zonisamide Market Drivers
8.3 Zonisamide Market Challenges
8.4 Zonisamide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Zonisamide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Zonisamide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Zonisamide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Zonisamide Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Zonisamide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Zonisamide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Zonisamide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Zonisamide Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Zonisamide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Zonisamide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Zonisamide, Product Type & Application
Table 12. Global Key Manufacturers of Zonisamide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Zonisamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zonisamide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Zonisamide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Zonisamide Sales by Region (2019-2024) & (K Units)
Table 18. Global Zonisamide Sales Market Share by Region (2019-2024)
Table 19. Global Zonisamide Sales by Region (2025-2030) & (K Units)
Table 20. Global Zonisamide Sales Market Share by Region (2025-2030)
Table 21. Global Zonisamide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Zonisamide Revenue Market Share by Region (2019-2024)
Table 23. Global Zonisamide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Zonisamide Revenue Market Share by Region (2025-2030)
Table 25. North America Zonisamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Zonisamide Sales by Country (2019-2024) & (K Units)
Table 27. North America Zonisamide Sales by Country (2025-2030) & (K Units)
Table 28. North America Zonisamide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Zonisamide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Zonisamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Zonisamide Sales by Country (2019-2024) & (K Units)
Table 32. Europe Zonisamide Sales by Country (2025-2030) & (K Units)
Table 33. Europe Zonisamide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Zonisamide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Zonisamide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Zonisamide Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Zonisamide Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Zonisamide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Zonisamide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Zonisamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Zonisamide Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Zonisamide Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Zonisamide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Zonisamide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Zonisamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Zonisamide Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Zonisamide Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Zonisamide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Zonisamide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Zonisamide Sales (K Units) by Type (2019-2024)
Table 51. Global Zonisamide Sales (K Units) by Type (2025-2030)
Table 52. Global Zonisamide Sales Market Share by Type (2019-2024)
Table 53. Global Zonisamide Sales Market Share by Type (2025-2030)
Table 54. Global Zonisamide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Zonisamide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Zonisamide Revenue Market Share by Type (2019-2024)
Table 57. Global Zonisamide Revenue Market Share by Type (2025-2030)
Table 58. Global Zonisamide Price (USD/Unit) by Type (2019-2024)
Table 59. Global Zonisamide Price (USD/Unit) by Type (2025-2030)
Table 60. Global Zonisamide Sales (K Units) by Application (2019-2024)
Table 61. Global Zonisamide Sales (K Units) by Application (2025-2030)
Table 62. Global Zonisamide Sales Market Share by Application (2019-2024)
Table 63. Global Zonisamide Sales Market Share by Application (2025-2030)
Table 64. Global Zonisamide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Zonisamide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Zonisamide Revenue Market Share by Application (2019-2024)
Table 67. Global Zonisamide Revenue Market Share by Application (2025-2030)
Table 68. Global Zonisamide Price (USD/Unit) by Application (2019-2024)
Table 69. Global Zonisamide Price (USD/Unit) by Application (2025-2030)
Table 70. Concordia Corporation Information
Table 71. Concordia Description and Business Overview
Table 72. Concordia Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Concordia Zonisamide Product
Table 74. Concordia Recent Developments/Updates
Table 75. Eisai Corporation Information
Table 76. Eisai Description and Business Overview
Table 77. Eisai Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eisai Zonisamide Product
Table 79. Eisai Recent Developments/Updates
Table 80. Zydus Pharmaceuticals Corporation Information
Table 81. Zydus Pharmaceuticals Description and Business Overview
Table 82. Zydus Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Zydus Pharmaceuticals Zonisamide Product
Table 84. Zydus Pharmaceuticals Recent Developments/Updates
Table 85. Sun Pharma Corporation Information
Table 86. Sun Pharma Description and Business Overview
Table 87. Sun Pharma Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sun Pharma Zonisamide Product
Table 89. Sun Pharma Recent Developments/Updates
Table 90. Wockhardt Corporation Information
Table 91. Wockhardt Description and Business Overview
Table 92. Wockhardt Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Wockhardt Zonisamide Product
Table 94. Wockhardt Recent Developments/Updates
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Mylan Zonisamide Product
Table 99. Mylan Recent Developments/Updates
Table 100. APOTEX Corporation Information
Table 101. APOTEX Description and Business Overview
Table 102. APOTEX Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. APOTEX Zonisamide Product
Table 104. APOTEX Recent Developments/Updates
Table 105. Teva Corporation Information
Table 106. Teva Description and Business Overview
Table 107. Teva Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Teva Zonisamide Product
Table 109. Teva Recent Developments/Updates
Table 110. Glenmark Corporation Information
Table 111. Glenmark Description and Business Overview
Table 112. Glenmark Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Glenmark Zonisamide Product
Table 114. Glenmark Recent Developments/Updates
Table 115. Bluepharma Corporation Information
Table 116. Bluepharma Description and Business Overview
Table 117. Bluepharma Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Bluepharma Zonisamide Product
Table 119. Bluepharma Recent Developments/Updates
Table 120. Invagen Pharmaceuticals Corporation Information
Table 121. Invagen Pharmaceuticals Description and Business Overview
Table 122. Invagen Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Invagen Pharmaceuticals Zonisamide Product
Table 124. Invagen Pharmaceuticals Recent Developments/Updates
Table 125. Intas Pharmaceuticals Corporation Information
Table 126. Intas Pharmaceuticals Description and Business Overview
Table 127. Intas Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Intas Pharmaceuticals Zonisamide Product
Table 129. Intas Pharmaceuticals Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Zonisamide Distributors List
Table 133. Zonisamide Customers List
Table 134. Zonisamide Market Trends
Table 135. Zonisamide Market Drivers
Table 136. Zonisamide Market Challenges
Table 137. Zonisamide Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Zonisamide
Figure 2. Global Zonisamide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Zonisamide Market Share by Type in 2023 & 2030
Figure 4. 25mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. 100mg Product Picture
Figure 7. Global Zonisamide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Zonisamide Market Share by Application in 2023 & 2030
Figure 9. Adult
Figure 10. Pediatric
Figure 11. Geriatric
Figure 12. Global Zonisamide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Zonisamide Market Size (2019-2030) & (US$ Million)
Figure 14. Global Zonisamide Sales (2019-2030) & (K Units)
Figure 15. Global Zonisamide Average Price (USD/Unit) & (2019-2030)
Figure 16. Zonisamide Report Years Considered
Figure 17. Zonisamide Sales Share by Manufacturers in 2023
Figure 18. Global Zonisamide Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Zonisamide Players: Market Share by Revenue in 2023
Figure 20. Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Zonisamide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Zonisamide Sales Market Share by Country (2019-2030)
Figure 23. North America Zonisamide Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Zonisamide Sales Market Share by Country (2019-2030)
Figure 27. Europe Zonisamide Revenue Market Share by Country (2019-2030)
Figure 28. Germany Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Zonisamide Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Zonisamide Revenue Market Share by Region (2019-2030)
Figure 35. China Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Zonisamide Sales Market Share by Country (2019-2030)
Figure 46. Latin America Zonisamide Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Zonisamide Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Zonisamide Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Zonisamide by Type (2019-2030)
Figure 56. Global Revenue Market Share of Zonisamide by Type (2019-2030)
Figure 57. Global Zonisamide Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Zonisamide by Application (2019-2030)
Figure 59. Global Revenue Market Share of Zonisamide by Application (2019-2030)
Figure 60. Global Zonisamide Price (USD/Unit) by Application (2019-2030)
Figure 61. Zonisamide Value Chain
Figure 62. Zonisamide Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Zonisamide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Zonisamide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Zonisamide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Zonisamide Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Zonisamide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Zonisamide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Zonisamide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Zonisamide Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Zonisamide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Zonisamide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Zonisamide, Product Type & Application
Table 12. Global Key Manufacturers of Zonisamide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Zonisamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zonisamide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Zonisamide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Zonisamide Sales by Region (2019-2024) & (K Units)
Table 18. Global Zonisamide Sales Market Share by Region (2019-2024)
Table 19. Global Zonisamide Sales by Region (2025-2030) & (K Units)
Table 20. Global Zonisamide Sales Market Share by Region (2025-2030)
Table 21. Global Zonisamide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Zonisamide Revenue Market Share by Region (2019-2024)
Table 23. Global Zonisamide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Zonisamide Revenue Market Share by Region (2025-2030)
Table 25. North America Zonisamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Zonisamide Sales by Country (2019-2024) & (K Units)
Table 27. North America Zonisamide Sales by Country (2025-2030) & (K Units)
Table 28. North America Zonisamide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Zonisamide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Zonisamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Zonisamide Sales by Country (2019-2024) & (K Units)
Table 32. Europe Zonisamide Sales by Country (2025-2030) & (K Units)
Table 33. Europe Zonisamide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Zonisamide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Zonisamide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Zonisamide Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Zonisamide Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Zonisamide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Zonisamide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Zonisamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Zonisamide Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Zonisamide Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Zonisamide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Zonisamide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Zonisamide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Zonisamide Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Zonisamide Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Zonisamide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Zonisamide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Zonisamide Sales (K Units) by Type (2019-2024)
Table 51. Global Zonisamide Sales (K Units) by Type (2025-2030)
Table 52. Global Zonisamide Sales Market Share by Type (2019-2024)
Table 53. Global Zonisamide Sales Market Share by Type (2025-2030)
Table 54. Global Zonisamide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Zonisamide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Zonisamide Revenue Market Share by Type (2019-2024)
Table 57. Global Zonisamide Revenue Market Share by Type (2025-2030)
Table 58. Global Zonisamide Price (USD/Unit) by Type (2019-2024)
Table 59. Global Zonisamide Price (USD/Unit) by Type (2025-2030)
Table 60. Global Zonisamide Sales (K Units) by Application (2019-2024)
Table 61. Global Zonisamide Sales (K Units) by Application (2025-2030)
Table 62. Global Zonisamide Sales Market Share by Application (2019-2024)
Table 63. Global Zonisamide Sales Market Share by Application (2025-2030)
Table 64. Global Zonisamide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Zonisamide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Zonisamide Revenue Market Share by Application (2019-2024)
Table 67. Global Zonisamide Revenue Market Share by Application (2025-2030)
Table 68. Global Zonisamide Price (USD/Unit) by Application (2019-2024)
Table 69. Global Zonisamide Price (USD/Unit) by Application (2025-2030)
Table 70. Concordia Corporation Information
Table 71. Concordia Description and Business Overview
Table 72. Concordia Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Concordia Zonisamide Product
Table 74. Concordia Recent Developments/Updates
Table 75. Eisai Corporation Information
Table 76. Eisai Description and Business Overview
Table 77. Eisai Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eisai Zonisamide Product
Table 79. Eisai Recent Developments/Updates
Table 80. Zydus Pharmaceuticals Corporation Information
Table 81. Zydus Pharmaceuticals Description and Business Overview
Table 82. Zydus Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Zydus Pharmaceuticals Zonisamide Product
Table 84. Zydus Pharmaceuticals Recent Developments/Updates
Table 85. Sun Pharma Corporation Information
Table 86. Sun Pharma Description and Business Overview
Table 87. Sun Pharma Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sun Pharma Zonisamide Product
Table 89. Sun Pharma Recent Developments/Updates
Table 90. Wockhardt Corporation Information
Table 91. Wockhardt Description and Business Overview
Table 92. Wockhardt Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Wockhardt Zonisamide Product
Table 94. Wockhardt Recent Developments/Updates
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Mylan Zonisamide Product
Table 99. Mylan Recent Developments/Updates
Table 100. APOTEX Corporation Information
Table 101. APOTEX Description and Business Overview
Table 102. APOTEX Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. APOTEX Zonisamide Product
Table 104. APOTEX Recent Developments/Updates
Table 105. Teva Corporation Information
Table 106. Teva Description and Business Overview
Table 107. Teva Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Teva Zonisamide Product
Table 109. Teva Recent Developments/Updates
Table 110. Glenmark Corporation Information
Table 111. Glenmark Description and Business Overview
Table 112. Glenmark Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Glenmark Zonisamide Product
Table 114. Glenmark Recent Developments/Updates
Table 115. Bluepharma Corporation Information
Table 116. Bluepharma Description and Business Overview
Table 117. Bluepharma Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Bluepharma Zonisamide Product
Table 119. Bluepharma Recent Developments/Updates
Table 120. Invagen Pharmaceuticals Corporation Information
Table 121. Invagen Pharmaceuticals Description and Business Overview
Table 122. Invagen Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Invagen Pharmaceuticals Zonisamide Product
Table 124. Invagen Pharmaceuticals Recent Developments/Updates
Table 125. Intas Pharmaceuticals Corporation Information
Table 126. Intas Pharmaceuticals Description and Business Overview
Table 127. Intas Pharmaceuticals Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Intas Pharmaceuticals Zonisamide Product
Table 129. Intas Pharmaceuticals Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Zonisamide Distributors List
Table 133. Zonisamide Customers List
Table 134. Zonisamide Market Trends
Table 135. Zonisamide Market Drivers
Table 136. Zonisamide Market Challenges
Table 137. Zonisamide Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Zonisamide
Figure 2. Global Zonisamide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Zonisamide Market Share by Type in 2023 & 2030
Figure 4. 25mg Product Picture
Figure 5. 50mg Product Picture
Figure 6. 100mg Product Picture
Figure 7. Global Zonisamide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Zonisamide Market Share by Application in 2023 & 2030
Figure 9. Adult
Figure 10. Pediatric
Figure 11. Geriatric
Figure 12. Global Zonisamide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Zonisamide Market Size (2019-2030) & (US$ Million)
Figure 14. Global Zonisamide Sales (2019-2030) & (K Units)
Figure 15. Global Zonisamide Average Price (USD/Unit) & (2019-2030)
Figure 16. Zonisamide Report Years Considered
Figure 17. Zonisamide Sales Share by Manufacturers in 2023
Figure 18. Global Zonisamide Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Zonisamide Players: Market Share by Revenue in 2023
Figure 20. Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Zonisamide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Zonisamide Sales Market Share by Country (2019-2030)
Figure 23. North America Zonisamide Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Zonisamide Sales Market Share by Country (2019-2030)
Figure 27. Europe Zonisamide Revenue Market Share by Country (2019-2030)
Figure 28. Germany Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Zonisamide Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Zonisamide Revenue Market Share by Region (2019-2030)
Figure 35. China Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Zonisamide Sales Market Share by Country (2019-2030)
Figure 46. Latin America Zonisamide Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Zonisamide Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Zonisamide Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Zonisamide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Zonisamide by Type (2019-2030)
Figure 56. Global Revenue Market Share of Zonisamide by Type (2019-2030)
Figure 57. Global Zonisamide Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Zonisamide by Application (2019-2030)
Figure 59. Global Revenue Market Share of Zonisamide by Application (2019-2030)
Figure 60. Global Zonisamide Price (USD/Unit) by Application (2019-2030)
Figure 61. Zonisamide Value Chain
Figure 62. Zonisamide Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232